Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cocktail formula versus ropivacaine acupoint injection for perioperative analgesia after mixed hemorrhoid surgery
ChiCTR2400082543Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine, dexamethasone, magnesium sulfate and sodium bicarbonate in hemorrhoid (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of moderate to severe pain at first postoperative dressing change. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
ropivacainedexamethasonemagnesium sulfatesodium bicarbonate
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ChiCTR2400082543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082543.